OSTN and Myocardial fibrosis: Musclin was found to attenuate cardiac dysfunction and myocardial fibrosis by augmenting the CNP/NPR-B-stimulated crosstalk of cGMP and cAMP in cardiomyocytes and by inhibiting p38 MAP kinase (MAPK) signaling through the activation of PKG in cardiac fibroblasts.